What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Nifedipine Extended Release Tablets market?

Key drivers include rising hypertension prevalence and growing demand for extended-release formulations.

What challenges does the Nifedipine Extended Release Tablets market face?

Challenges include patent expirations, generic competition, and stringent regulatory requirements.

Which regions are the leaders in the Nifedipine Extended Release Tablets market?

North America and Europe are the leading regions, driven by high healthcare expenditure.

Who are the top companies in the Nifedipine Extended Release Tablets market?

Top companies include Pfizer, Novartis, and Mylan, with a strong portfolio of extended-release products.

What future opportunities exist in the Nifedipine Extended Release Tablets market?

Future opportunities include emerging markets, novel formulations, and combination therapies.

How will technology impact the Nifedipine Extended Release Tablets market?

Technology advancements will drive innovation in formulation development and manufacturing processes.

What is the current regulatory landscape for the Nifedipine Extended Release Tablets market?

The regulatory landscape is characterized by stringent FDA and EMA guidelines, ensuring product quality and safety.

What is the future outlook for the Nifedipine Extended Release Tablets market?

The future outlook is positive, with growing demand and increasing adoption of extended-release formulations.

Nifedipine Extended Release Tablets Growth, Trends & Forecast Outlook 2033

Nifedipine Extended Release Tablets by Application (Hospital, Pharmacy, Others), by Types (Original Drug, Generic Drug), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Nifedipine Extended Release Tablets Market Size | CAGR 5.2 Forecast 2033

Nifedipine Extended Release Tablets Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Nifedipine Extended Release Tablets Market Overview

The Nifedipine Extended Release Tablets market refers to the global industry involved in the development, production, and distribution of extended-release tablets containing the medication nifedipine, which is used to treat hypertension and angina. As the Nifedipine Extended Release Tablets market size is expected to witness significant growth, driven by an increasing prevalence of cardiovascular diseases and an aging population, the growth outlook and market forecast are critical for industry stakeholders. The current Nifedipine Extended Release Tablets market size is approximately $1.3 billion, and the market is expected to grow at a CAGR of around 4-5% during the forecast period, driven by factors such as technological advancements, changing regulatory landscape, and shifting consumer behavior, ultimately contributing to the industry expansion.

Loading chart…

Key forces shaping the Nifedipine Extended Release Tablets market include technology shifts towards more efficient and patient-centric drug delivery systems, regulations related to drug safety and efficacy, and consumer behavior driven by increasing health awareness and demand for convenient treatment options. The largest region in the Nifedipine Extended Release Tablets market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rapid population growth, urbanization, and improving healthcare infrastructure. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends, opportunities, and challenges to make informed decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	3.45 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Valeant Pharmaceuticals; Zydus Pharmaceuticals Inc; Aurobindo Pharma LTD; Pfizer Inc; Sun Pharma Industries LTD; Osmotica Pharmaceuticals; Alkem Laboratories Ltd.; Novast Laboratories, LTD; TWi Pharmaceuticals Inc.; Shyndec Pharmaceutical Co.,Ltd; China National Pharmaceutical Industry Co.,Ltd; China Resource Pharmaceutical Group Co.,Ltd; Anglikang Pharmaceutical Co.,Ltd; Warrant Chiral Pharmaceutical Co.,Ltd; Tailison Pharmaceutical Co.,Ltd; Baheal Medical Inc.; Bocheng Pharmaceutical Co.,Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nifedipine Extended Release Tablets market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Nifedipine Extended Release Tablets market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of hypertension and cardiovascular diseases is driving the demand for Nifedipine Extended Release Tablets, leading to a substantial growth forecast for the market.

Advancements in drug delivery technology have improved the efficacy and safety of Nifedipine Extended Release Tablets, further boosting their adoption and contributing to the growth of the Nifedipine Extended Release Tablets market size.

Restraints2 items

Stringent regulatory requirements and intense competition in the pharmaceutical industry are constraining the growth of the Nifedipine Extended Release Tablets market, affecting the overall Nifedipine Extended Release Tablets market size.

Patent expirations and the rise of generic versions of Nifedipine Extended Release Tablets are expected to hinder the growth forecast of the market, as they may lead to decreased revenue for pharmaceutical companies.

Opportunities2 items

Emerging markets in Asia and Latin America offer significant opportunities for the growth of the Nifedipine Extended Release Tablets market, driven by increasing healthcare expenditure and a rising awareness of cardiovascular diseases.

The development of novel formulations and combination therapies with Nifedipine Extended Release Tablets is expected to create new avenues for growth and expansion in the Nifedipine Extended Release Tablets market, driving the growth forecast.

Challenges2 items

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Nifedipine Extended Release Tablets, posing a challenge to the growth of the Nifedipine Extended Release Tablets market size.

The Nifedipine Extended Release Tablets market is highly competitive, and pharmaceutical companies must invest heavily in research and development to stay competitive and achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Nifedipine Extended Release Tablets segmentation by application includes various therapeutic areas where these tablets are utilized. The primary applications of Nifedipine Extended Release Tablets are in the treatment of hypertension and angina. This segmentation contributes significantly to the overall market size, as it highlights the specific areas where the demand for these tablets is highest. Understanding the application segment is crucial for manufacturers to tailor their production and marketing strategies to meet the needs of different patient groups.

The types of Nifedipine Extended Release Tablets include various subtypes, such as [object Object] and [object Object]. These subtypes differ in terms of their formulation, dosage, and release mechanism. The types segment is essential in determining the overall market size, as it affects the pricing, competition, and patient compliance. By analyzing the types of Nifedipine Extended Release Tablets, manufacturers can identify opportunities to develop new products that address specific patient needs and preferences, ultimately driving growth in the Nifedipine Extended Release Tablets market.

Nifedipine Extended Release Tablets Segmentation Breakdown7 items

Application

Hospital

Pharmacy

Others

Types

Original Drug

Generic Drug

Regional Insights

Loading chart…

The Nifedipine Extended Release Tablets market growth is anticipated to be driven by various regional factors. North America, with a significant share of the market, is expected to be the largest region, driven by key drivers such as high adoption rates, favorable policies, and substantial investments in healthcare infrastructure. The Asia Pacific region is expected to be the fastest-growing region, driven by growing demographics, expanding ecosystem maturity, and increasing investments in pharmaceutical research and development.

In Europe, key drivers include established infrastructure, mature ecosystem, and strong regulatory framework. Latin America's growth is expected to be driven by growing demand, improving infrastructure, and increasing access to healthcare services. The Middle East & Africa region is expected to be driven by growing investments, expanding demographics, and improving adoption rates of Nifedipine Extended Release Tablets. These regional factors will contribute to the overall Nifedipine Extended Release Tablets market forecast.

Competitive Landscape

The Nifedipine Extended Release Tablets market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Nifedipine Extended Release Tablets competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players are increasingly focusing on emerging markets, while local companies are leveraging their regional strengths to compete with multinational corporations.

Companies in this market are adopting common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profitability. To mitigate these risks, companies are focusing on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. The following companies are employing distinct strategies:

Valeant Pharmaceuticals: regional expansion

Zydus Pharmaceuticals Inc: innovation pipeline

Aurobindo Pharma LTD: local manufacturing

Pfizer Inc: premium pricing

Sun Pharma Industries LTD: vertical integration

Osmotica Pharmaceuticals: OEM tie-ups

Key Nifedipine Extended Release Tablets Companies17 items

Valeant Pharmaceuticals

Zydus Pharmaceuticals Inc

Aurobindo Pharma LTD

Pfizer Inc

Sun Pharma Industries LTD

Osmotica Pharmaceuticals

Alkem Laboratories Ltd.

Novast Laboratories, LTD

TWi Pharmaceuticals Inc.

Shyndec Pharmaceutical Co.,Ltd

China National Pharmaceutical Industry Co.,Ltd

China Resource Pharmaceutical Group Co.,Ltd

Anglikang Pharmaceutical Co.,Ltd

Warrant Chiral Pharmaceutical Co.,Ltd

Tailison Pharmaceutical Co.,Ltd

Baheal Medical Inc.

Bocheng Pharmaceutical Co.,Ltd

Market Ecosystem

The Nifedipine Extended Release Tablets ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This ecosystem is bounded by the creation and capture of value, from the supply of raw materials to the delivery of finished products to end users. The value chain analysis of this ecosystem reveals the intricate relationships between various participants, influencing the overall efficiency and effectiveness of the ecosystem.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Nifedipine Extended Release Tablets

Distributors / channel partners — delivering products to pharmacies and hospitals

Regulators/standards bodies — overseeing compliance with regulatory requirements

Service providers / after-sales — offering support and maintenance services

End users / buyers — purchasing and administering Nifedipine Extended Release Tablets

Data/analytics providers — supplying market insights and research data

The flow of value within the Nifedipine Extended Release Tablets ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact the adoption of products. Dependency risks, including input constraints and switching costs, can also affect the ecosystem's dynamics. Moreover, the ecosystem's structure and participants may vary by region, leading to differences in how value is created and captured. Understanding these factors is essential for navigating the complex Nifedipine Extended Release Tablets ecosystem.

Recent Industry Insights

The Nifedipine Extended Release Tablets industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies have led to the expansion of product portfolios and enhanced distribution networks. Notable mergers and acquisitions have also taken place, resulting in increased market consolidation and competitiveness. Furthermore, several product launches have introduced new formulations and dosages, catering to diverse patient needs and preferences. Regulatory changes, such as updated labeling requirements, have ensured improved patient safety and efficacy. A shift in consumer trends towards personalized medicine has driven the demand for extended-release formulations, including Nifedipine Extended Release Tablets. Funding rounds and expansions have enabled companies to invest in research and development, driving innovation and growth in the Nifedipine Extended Release Tablets market.

Analyst Overview

As the Lead Analyst, my expert view on the Nifedipine Extended Release Tablets market outlook is that it presents a moderately attractive opportunity, driven by the growing prevalence of hypertension and cardiovascular diseases. The competitive intensity is relatively high, with multiple players operating in the market.

The long-term outlook for the market appears promising, with a steady demand for extended release formulations. However, the innovation landscape is relatively stagnant, with limited new product launches. The demand-supply balance is expected to remain stable, with key players maintaining their market share. Key risk factors include regulatory challenges and intense competition, which may impact market growth.

11 items

1. Executive Summary

2. Nifedipine Extended Release Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nifedipine Extended Release Tablets Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Nifedipine Extended Release Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Pharmacy

6.1.3. Others

6.2. Global Nifedipine Extended Release Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Original Drug

6.2.2. Generic Drug

6.3. Global Nifedipine Extended Release Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Nifedipine Extended Release Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nifedipine Extended Release Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nifedipine Extended Release Tablets Market Competition by Key Manufacturers

8.1. Global Nifedipine Extended Release Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Nifedipine Extended Release Tablets: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Valeant Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zydus Pharmaceuticals Inc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aurobindo Pharma LTD

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Pfizer Inc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sun Pharma Industries LTD

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Osmotica Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Alkem Laboratories Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Novast Laboratories, LTD

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. TWi Pharmaceuticals Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Shyndec Pharmaceutical Co.,Ltd

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. China National Pharmaceutical Industry Co.,Ltd

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. China Resource Pharmaceutical Group Co.,Ltd

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Anglikang Pharmaceutical Co.,Ltd

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Warrant Chiral Pharmaceutical Co.,Ltd

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Tailison Pharmaceutical Co.,Ltd

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Baheal Medical Inc.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Bocheng Pharmaceutical Co.,Ltd

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nifedipine Extended Release Tablets Market

Figure 4: Global Nifedipine Extended Release Tablets Market: Drivers

Figure 5: Global Nifedipine Extended Release Tablets Market: Challenges

Figure 6: Global Nifedipine Extended Release Tablets Market: Trends

Figure 7: Global Nifedipine Extended Release Tablets Market: Opportunity

Figure 8: Global Nifedipine Extended Release Tablets Market: Restraint

Figure 9: Global Nifedipine Extended Release Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Nifedipine Extended Release Tablets Market Value (USD Million) By Region

Figure 15: Global Nifedipine Extended Release Tablets Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Nifedipine Extended Release Tablets Market Value (USD Million) By Region

Figure 23: Global Nifedipine Extended Release Tablets Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Nifedipine Extended Release Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nifedipine Extended Release Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nifedipine Extended Release Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Nifedipine Extended Release Tablets Market Value (USD Million) By Region

Table 10: Global Nifedipine Extended Release Tablets Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Nifedipine Extended Release Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Nifedipine Extended Release Tablets Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Nifedipine Extended Release Tablets Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Valeant Pharmaceuticals Basic Information And Sales Area

Table 31: Valeant Pharmaceuticals. Products Portfolio

Table 32: Zydus Pharmaceuticals Inc Basic Information And Sales Area

Table 33: Zydus Pharmaceuticals Inc. Products Portfolio

Table 34: Aurobindo Pharma LTD Basic Information And Sales Area

Table 35: Aurobindo Pharma LTD. Products Portfolio

Table 36: Pfizer Inc Basic Information And Sales Area

Table 37: Pfizer Inc. Products Portfolio

Table 38: Sun Pharma Industries LTD Basic Information And Sales Area

Table 39: Sun Pharma Industries LTD. Products Portfolio

Table 40: Osmotica Pharmaceuticals Basic Information And Sales Area

Table 41: Osmotica Pharmaceuticals. Products Portfolio

Table 42: Alkem Laboratories Ltd. Basic Information And Sales Area

Table 43: Alkem Laboratories Ltd.. Products Portfolio

Table 44: Novast Laboratories, LTD Basic Information And Sales Area

Table 45: Novast Laboratories, LTD. Products Portfolio

Table 46: TWi Pharmaceuticals Inc. Basic Information And Sales Area

Table 47: TWi Pharmaceuticals Inc.. Products Portfolio

Table 48: Shyndec Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 49: Shyndec Pharmaceutical Co.,Ltd. Products Portfolio

Table 50: China National Pharmaceutical Industry Co.,Ltd Basic Information And Sales Area

Table 51: China National Pharmaceutical Industry Co.,Ltd. Products Portfolio

Table 52: China Resource Pharmaceutical Group Co.,Ltd Basic Information And Sales Area

Table 53: China Resource Pharmaceutical Group Co.,Ltd. Products Portfolio

Table 54: Anglikang Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 55: Anglikang Pharmaceutical Co.,Ltd. Products Portfolio

Table 56: Warrant Chiral Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 57: Warrant Chiral Pharmaceutical Co.,Ltd. Products Portfolio

Table 58: Tailison Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 59: Tailison Pharmaceutical Co.,Ltd. Products Portfolio

Table 60: Baheal Medical Inc. Basic Information And Sales Area

Table 61: Baheal Medical Inc.. Products Portfolio

Table 62: Bocheng Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 63: Bocheng Pharmaceutical Co.,Ltd. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Nifedipine Extended Release Tablets Market Value (USD Million) By Region

Table 69: Global Nifedipine Extended Release Tablets Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nifedipine Extended Release Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	3.45 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Valeant Pharmaceuticals; Zydus Pharmaceuticals Inc; Aurobindo Pharma LTD; Pfizer Inc; Sun Pharma Industries LTD; Osmotica Pharmaceuticals; Alkem Laboratories Ltd.; Novast Laboratories, LTD; TWi Pharmaceuticals Inc.; Shyndec Pharmaceutical Co.,Ltd; China National Pharmaceutical Industry Co.,Ltd; China Resource Pharmaceutical Group Co.,Ltd; Anglikang Pharmaceutical Co.,Ltd; Warrant Chiral Pharmaceutical Co.,Ltd; Tailison Pharmaceutical Co.,Ltd; Baheal Medical Inc.; Bocheng Pharmaceutical Co.,Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options